GVK Bio under scanner of European Drug Regulator
The European Medicines Agency (EMA) has started a review in connection with findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences, a city-based Contract Research Organisation.
Oct 01, 2014, 17:29 PM IST